U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381322) titled 'A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI' on Jan. 25.
Brief Summary: This project aims to use multi-temporal, multi-parameter MRI features, blood biomarkers, and clinical indicators to accurately assess pseudoprogression following immunotherapy in rectal cancer.
Study Start Date: Jan. 30
Study Type: OBSERVATIONAL
Condition:
Rectal
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Peiyi Xie
Information provided by (Responsible Party): Peiyi Xie, Sixth Affiliated Hospital, Sun Yat-sen University
Disclaimer: Curated by HT Syndication....